The research-based pharmaceutical industry is one of the most technically complex of all, and naturally places itself in a small group of industries referred to as high technology, or 'high-tech', industries.
Figure 1 – Top world pharmaceutical corporations, 2011
The table below shows the top 15 pharmaceutical corporations operating on the global market. 'Nationality' of a corporation indicates the country where it is headquartered, 'growth' indicates the annual average growth from the previous year (ie from 2010), and 'market share' is given as percentage of the global market.
| 1 |
Pfizer |
USA |
-1% |
6.6% |
|---|
| 2 |
Novartis |
CH |
10% |
6% |
|---|
| 3 |
Merck & Co |
USA |
7% |
4.7% |
|---|
| 4 |
Sanofi |
F |
3% |
4.6% |
|---|
| 5 |
Astrazeneca |
GB |
3% |
4.3% |
|---|
| 6 |
Roche |
CH |
6% |
4% |
|---|
| 7 |
GlaxoSmithKline |
GB |
1% |
4% |
|---|
| 8 |
Johnson & Johnson |
USA |
0% |
3.2% |
|---|
| 9 |
Abbott |
USA |
7% |
3% |
|---|
| 10 |
Teva |
ISR |
-2% |
2.8% |
|---|
| 11 |
Lilly |
USA |
7% |
2.8% |
|---|
| 12 |
Takeda |
J |
6% |
2.1% |
|---|
| 13 |
Bristol-Myers Squibb |
USA |
10% |
1.9% |
|---|
| 14 |
Bayer Schering Pharma |
D |
4% |
1.9% |
|---|
Source: IMS Health World Review Analyst 2012 
www.imshealth.com